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Abstract—Estimating the individual treatment effect (ITE)
from observational data is meaningful and practical in health-
care. Existing work mainly relies on the strong ignorability
assumption that no hidden confounders exist, which may lead
to bias in estimating causal effects. Some studies consider the
hidden confounders are designed for static environment and not
easily adaptable to a dynamic setting. In fact, most observational
data (e.g., electronic medical records) is naturally dynamic and
consists of sequential information. In this paper, we propose Deep
Sequential Weighting (DSW) for estimating ITE with time-varying
confounders. Specifically, DSW infers the hidden confounders by
incorporating the current treatment assignments and historical
information using a deep recurrent weighting neural network.
The learned representations of hidden confounders combined
with current observed data are leveraged for potential outcome
and treatment predictions. We compute the time-varying in-
verse probabilities of treatment for re-weighting the population.
We conduct comprehensive comparison experiments on fully-
synthetic, semi-synthetic and real-world datasets to evaluate the
performance of our model and baselines. Results demonstrate
that our model can generate unbiased and accurate treatment
effect by conditioning both time-varying observed and hidden
confounders, paving the way for personalized medicine.
Index Terms—deep learning, electronic medical record, ITE,
time-varying confounders
I. INTRODUCTION
Estimating the individual treatment effect (ITE) is a task of
evaluating the causal effect of treatment strategies on some
important outcomes over individual-level, which is a signifi-
cant problem in many areas [1]–[5]. For example, in healthcare
domain, it is critical to prescribe personalized medicines (treat-
ments) for different patients based on their health conditions.
To approach this, randomized controlled trial (RCT) is usually
conducted, which is accomplished by randomly allocating
patients to two groups, treating them differently (i.e., one
group has intervention and the other has a placebo or no
intervention) and comparing them in terms of a measured
response. However, conducting RCTs in the healthcare domain
is extremely expensive and time-consuming, if not impossible,
due to the requirement of tremendous expert effort and the
consideration of ethical issues.
Observational data contain patient records, including their
demographic information, vital signs, lab tests and outcomes
but without having complete knowledge of why a specific
treatment is applied to a patient. The accumulation of ob-
servational data in electronic medical records (EMRs) offers
a promising opportunity for ITE estimation when RCTs are
expensive or impossible to conduct.
Xt
Zt-1
At
Xt+1
Zt
At+1
XT
ZT-1
AT YT+t...
...
...
Timet t+1 T
Fig. 1. The illustration of causal graphs for causal estimation from dy-
namic observational data. During observed window T , we have a trajectory
{Xt, At, Zt−1}Tt=1 ∪ {YT+t}, where Xt denotes the current observed
covariates, At denotes the treatment assignments, Zt denotes the hidden
confounders and YT+t denotes the potential outcomes. At any time stamp
t, the treatment assignments At are affected by both observed covariates
Xt and hidden confounders Zt−1 (the causal relationship are annotated
by blue arrows). The hidden confounders Zt−1 are inferred from previous
hidden confounders, treatments and covariates (annotated by black arrows).
The potential outcomes YT+t are affected by last time stamp covariates XT ,
treatment assignments AT and hidden confounders ZT−1.
There have been lots of existing methods that estimate
ITE by leveraging observational data, including propensity
score matching method [6], forest based methods [7], [8],
and representation learning-based methods [9]–[11]. However,
many methods are mainly based on the strong ignorability
assumption that there are no unobserved confounders and
only few studies have considered the influence of hidden
confounders [12]. Here, the hidden confounders refer to factors
that affect both treatment assignment and outcome, but are
not directly measured in the observational data. For example,
physicians may prescribe treatments to the patient based on
indicators not in the medical records. Ignoring these hidden
confounders can lead to bias in estimating causal effects
[13]. Besides, these methods are primarily designed for static
settings and are hardly extended to longitudinal observation
data. However, most real-world observational data is naturally
dynamic and consists of sequential information. For example,
in EMR, the patient’s conditions (e.g., prescribed medicines,
lab results and vital signs) and treatment assignments are
recorded frequently during their stay in the hospital. Therefore,
estimating ITE becomes more challenging when the treatments
and covariates change over time, and the potential outcomes
are influenced by historical treatments and covariates.
In this paper, we study the problem of Estimating indi-
vidual treatment effects with time-varying confounders (as
illustrated by a causal graph in Fig 1). To alleviate the
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aforementioned challenges, we propose a novel causal effects
estimation framework, Deep Sequential Weighting (DSW), to
adjust the time-varying confounders in the longitudinal data.
The proposed framework DSW consists of three main com-
ponents: representation learning module, balancing module
and prediction module. To adjust the time-varying hidden
confounders, DSW first learns the representations of hidden
confounders by leveraging the current observed covariates
and all historical information (i.e., previous covariates and
treatment assignments) through Gated Recurrent Units (GRU)
with an attention mechanism. With the help of the attention
mechanism, the model can automatically focus on important
historical information. Then, we compute the time-varying
inverse probability of treatment for each individual to balance
the confounding. The learned representations of hidden con-
founders and observed covariates are then combined together
for both treatment prediction and potential outcome prediction.
To demonstrate the effectiveness of our framework, we con-
duct comprehensive experiments on synthetic, semi-synthetic
and real-world EMR datasets (MIMIC-III [14]). DSW out-
performs state-of-the-art baselines in terms of PEHE and
ATE. To further illustrate how our method can be used in
personalized medicine, we analyze the treatment effects on im-
portant outcomes for ICU septic patients. Results demonstrate
that our model can generate unbiased and accurate treatment
effect by conditioning both time-varying observed confounders
and hidden confounders. Our model has the potential to be
leveraged as part of clinical decision support systems that
assist physicians to determine whether to introduce treatment
to a patient or a specific population.
The contributions of this paper are as follows:
• We study the task of estimating ITE with time-varying
confounders, on which few attention has been before.
• We propose a novel causal inference framework DSW to
solve the task. DSW fully utilize the historical information
and current covariates for learning the representations of
hidden confounders. A balancing operation is adopted to
generate unbiased and accurate ITE estimation.
• We conduct experiments on synthetic, semi-synthetic and
real-world datasets to demonstrate the effectiveness of our
proposed method. Results show that our method outper-
forms state-of-the-art causal inference methods and has
the potential to be used as part of clinical decision support
systems to determine whether a treatment is needed
for a specific patient, paving the way for personalized
medicine.
II. METHOD
In this section, we first give a formal definition of the
notations used throughout the paper, then present the proposed
framework for estimating ITE.
A. Preliminary
Let Xt ∈ Xt be the time-dependent covariates of
the observational data at time stamp t such that Xt =
{x(1)t , x(2)t , ..., x(n)t }, where x(i)t denotes the covariates for
TABLE I
Notations
Notation Definition
X The space of time-varying covariates
C The space of static covariates
A The set of treatment options of interest
Y The space of potential outcomes
Xt The time-varying covariates of all patients at time t
Z The space of hidden confounders
x
(i)
t The time-varying covariates of i-th patient at time t
C The static covariates of all patients
c(i) The static covariates of i-th patient
At The treatment assigned at time t
a
(i)
t The treatment assigned for i-th patient at time t
YT+τ The factual (observed) outcomes at time T + τ
Y1,T+τ/Yˆ1,T+τ
The observed/predicted outcome at time T + τ when
receive treatment
y
(i)
1,T+τ/yˆ
(i)
1,T+τ
The observed/predicted outcomes of i-th patient at
time T + τ when a(i) = 1
Y0,T+τ/Yˆ0,T+τ
The observed/predicted outcome at time T + τ when
not receive the treatment
y
(i)
0,T+τ/yˆ
(i)
0,T+τ
The observed/predicted outcomes of i-th patient at
time T + τ when a(i) = 0
e(i)/eˆ(i) The true/predicted ITE of i-th patient at time t
(·)t The historical covariates collected before time t
Zt The learned hidden confounders at time t
z
(i)
t The learned hidden confounders for patient i at time t
H˜
(i)
t
The historical data consists of {x(i)t , a(i)t } ∪ {c(i)}
for i-th patient
T The number of time stamps (observation window)
τ The length of prediction window
n The number of patients in the dataset
i-th patient, n denotes the number of patients, and Xt de-
notes the time-dependent feature space. The static features
(e.g., demographic information), do not change overtime are
also considered as observed covariates. We use C ∈ C
represent the static features for all the patients. At each
time stamp t, the treatment assignments are denoted as
At = {a(1)t , a(2)t , ..., a(n)t }, where At ∈ A, a(i)t denotes the
treatments assigned to i-th patient. In the case of the binary
treatment setting, i.e., ait = {0, 1}, where 1 is considered as
”treated” while 0 as ”control”, we are interested in estimating
the effect of the treatment assigned until time stamp T on the
outcomes YT+τ ∈ Y , observed at time stamp T + τ , where
τ is the prediction window. Note that in observational data,
a patient can only belong to one group (i.e., either treated
or control group), thus the outcome from the other group is
always missing and referred to counterfactual. To represent
the historical sequential data before time stamp t, we use the
notation Xt = {X1, X2, ..., Xt−1} to denote the history of
covariates observed before time stamp t, and At refers to the
history of treatment assignments. Combining all covariates and
treatments, we define H˜(i)t = {x(i)t , a(i)t } ∪ {c(i)} as all the
historical data collected before time stamp t. The observational
data for i-th patient can be represented using the notations
defined above as: D(i) = {x(i)t , a(i)t }Tt=1 ∪ {c(i), y(i)a,T+τ}. We
summarize the notations we used in this paper in Table I.
We follow the well-adopted potential outcome framework
and its variation that considers the time-varying treatment
assignments when estimating the causal effect on the out-
comes. The potential outcome y(i)a,T+τ of i-th patient given
the historical treatment can be formulated as y(i)a,T+τ =
E[y|x(i)t ,H(i)t , a = a(i)], where a(i) equals to 1 if the treatment
is assigned at time {1, 2.., T}, otherwise 0. Then the individual
treatment effect (ITE) on the temporal observational data is
defined as follows:
e(i) = E[y(i)1,T+τ |x(i)t , a(i)t , H˜(i)t ]− E[y(i)0,T+τ |x(i)t , a(i)t , H˜(i)t ] (1)
Here, the observed outcome y(i)a,T+τ under treatment a is
called factual outcome, while the unobserved one y(i)1−a,T+τ
is the counterfactual outcome. In observational data, only
the factual outcomes are available, while the counterfactual
outcomes can never been observed.
B. Assumptions
Our estimation of ITE is based on the the following impor-
tant assumptions [15], and we further extend the assumptions
in our scenario (i.e., time-varying observational data).
Assumption 2.1 (Consistency): The potential outcome under
treatment history A equals to the observed outcome if the
actual treatments history is A.
Assumption 2.2 (Positivity): For any patient i, if the the
probability P(a(i)t−1, x
(i)
t , c
i) 6= 0, then the probability of re-
ceiving treatment 0 or 1 is positive, i.e., 0 < P(a(i)t , x
(i)
t , c
i) <
1, for all a(i)t .
Besides these two assumptions, many existing work are based
on strong ignorability assumption:
Assumption 2.3 (Strong Ignorability): Given the observed
historical covariates x(i)t and static covariates c
(i) of i-th pa-
tient, the potential outcome variables y(i)1,T+τ , y
(i)
0,T+τ are inde-
pendent of the treatment assignment, i.e., (y(i)1,T+τ , y
(i)
0,T+τ ) ⊥
a
(i)
t |x(i)t , c(i)
This assumption holds only if there exist no hidden con-
founders. However, this condition is hard to guarantee in prac-
tice especially in real-world observational data. In this paper,
we relax such strict assumption by introducing that there exist
potential hidden confounders. Our proposed method can learn
the representations of the hidden confounders and eliminate
the bias between the treatment assignments and outcomes
at each time stamp. The learned representations (denoted
by Zt ∈ Z) can be leveraged for inferring the unobserved
confounders and regarded as the substitutes of hidden con-
founders. Thus, we extend the strong ignorability assumption
by considering the existing of hidden confounders Zt at each
time stamp t, which influence the treatment assignment At
and potential outcomes YT+τ . Given the hidden confounders
Zt, the potential outcome variables are independent of the
treatment assignment at each time stamp.
C. Proposed Method
According to the aforementioned assumptions, we present
a novel method that utilizes current variables as well as
the historical data to learn the representations of the hidden
confounders and estimate the individual treatment effect (ITE)
for all patients. The overall framework of the proposed method
is illustrated in Fig. 2. We will illustrate the details of each
module in the following subsections.
D. Representation Learning Module
As the initial feature vectors are always high-dimensional
and sparse in the case of real-world data, we first convert
the initial features x(i)t ∈ Rdx of each patient into a lower-
dimensional and continuous data representations u(i)t ∈ Rdu ,
where du is the dimension of the embedded feature vectors,
using a liner embedding layer. That is, we define:
u
(i)
t = Wembx
(i)
t (2)
where Wemb ∈ Rdu×dx is the embedding matrix. Simply,
the liner embedding layer can be alternatively replaced by
other more complex embedding method such as multi-layer
perceptron (MLP) [16], which is also widely used in learning
representation of EMR data [17].
The representation of hidden confounders z(i)t is learned
through a GRU layer to capture the inherent characteristics
of time-varying observational data (i.e., dependency between
each time unit and sparsity). The current information u(i)t ,
treatment assignments a(i)t , last time stamp hidden con-
founders z(i)t−1 and last output hidden state of GRU h
(i)
t−1 are
regarded as the input to the GRU. For the convenience of
future prediction task, we concatenate the current information
u
(i)
t and last time stamp hidden confounders z
(i)
t−1 into a new
variable q(i)t as follows,
q
(i)
t = g([u
(i)
t , z
(i)
t−1]) (3)
where g(·) denotes the function for learning the hidden con-
founders (typically a MLP layer is used for generating the
representations), [·, ·] denotes the concatenation of two vectors.
We elaborate the the architecture of GRU as follows,
ft = σg(Wf [q
(i)
t , c
(i)
t ] + Vfht + bf )
rt = σg(Wr[q
(i)
t , c
(i)
t ] + Vrht + br)
h′t = Φh(Wh[q
(i)
t , c
(i)
t ] + Vf (rt  ht−1) + bh)
ht = ft  ht−1 + (1− ft) h′t
(4)
where σg is sigmoid function, Φh is hyperbolic tangent
function,  denotes element-wise product operation, Wf , Wr,
Wh ∈ Rdh×(dq+dc), Vf , Vr ∈ Rdh×dh , bf , br ∈ Rdh are
parameters matrices and vectors to learn. ft denotes the update
gate vector, rt denotes reset gate vector and ht denotes the
hidden output vector. The output vectors are further aggregated
via a attention layer for automatically focusing on important
historical time stamp. We can use various methods to calculate
the attention energies between the each previous hidden state
hs and current state ht, e.g., dot product h>t hs, linear attention
h>t Wαhs. In this paper, we calculate the attention weight αt,s
using a method that concatenates each previous hidden state
with the current state, and the product of two states. That is,
αt,s = score(ht, hs) = Φ(Wα[ht, hs, ht  hs])
αt = softmax(αt,1, αt,2, . . . , αt,t−1)
(5)
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Fig. 2. The framework of DSW. DSW contains three main modules: representation learning module, balancing module and prediction module. At each time
stamp t, the model takes the current covariates (Xt, C), treatment assignments At, along with the hidden variables Zt−1 as input for learning representations
of confounder Qt. The historical information is modeled via a gated recurrent unit (GRU) and aggregated through an attention layer. Then, we use the learned
representations of confounding variables for treatment prediction at each time stamp and final outcome prediction after time T .
where Φ is hyperbolic tangent function, Wα ∈ R3dh×dh
is learnable parameter matrix. Using the generated attention
energies, we can calculate the context vector ot for each patient
up to t time stamp as follows,
ot =
t−1∑
s=1
αt,shs (6)
We further concatenate the context vector with the current
hidden state to generate the current representations zt up to
time t:
zt = Φ(Wz[ht, ot]) (7)
where Wz ∈ R2dh is a learnable parameter matrix.
E. Prediction Module
After obtaining the hidden confounding representations, we
leverage them for treatment prediction at each time stamp
and final outcome prediction during the following prediction
window.
1) Global Max Pooling: As the time sequence increases,
basic RNN model may forget earlier information due to its
long-term dependency. Thus, we adopt a global max-pooling
operation over the concatenation of all outputs of q(i)t vectors.
As shown in Fig. 2, the output of max-pooling layer q(i)m are
further used for treatment prediction and potential outcome
prediction.
2) Treatment prediction: We predict the treatment assign-
ments for the patient at each time stamp regarding the q(i)m
and static demographic features c(i) as input, and the real
treatment a(i)t as the target label. The predicted treatments
aˆ
(i)
t are obtained through a fully-connected layer with sigmoid
function as the last layer,
aˆt = sigmoid(Wa[qm, c] + ba) (8)
where Wa ∈ Rdq+dc and ba ∈ R are learnable parameters,
aˆ
(i)
t denotes the the probability of receiving treatment based
on the potential confounders of patient i at time t. Typically,
the predicted results can also be referred as propensity score
[6] that aˆ(i)t = P(a
(i)
t = 1|u(i)t , z(i)t−1).
As we consider the binary treatment in this paper, we use a
cross-entropy loss for the treatment prediction over all patients
and all time stamps as follows,
La = − 1
N
1
T
N∑
i=1
T∑
t=1
(a
(i)
t log aˆ
(i)
t + (1− a(i)t ) log (1− aˆ(i)t )) (9)
3) Outcome prediction: We finally adopt a potential out-
come prediction network to estimate the the outcome yˆ(i)t,T+τ
by taking the hidden representations q(i)t from each time stamp
as input. Here, to fully utilize the time series information,
we use a max-pooling layer to aggregate all hidden represen-
tations. Let g(·) denotes the function learned from outcome
prediction network. Then we have,
yˆ
(i)
t,T+τ = g(q
(i)
m , a
(i) = t) (10)
where we estimate the potential outcome for each patient given
each treatment assignment situation. Here, we use MLPs to
model the function g(·). We minimize the factual loss function
as follows,
Ly = 1
N
N∑
i=1
w(i)a (yˆ
(i)
t,T+τ − y(i)t,T+τ )2 (11)
where w(i)a is to re-weight the population for adjusting con-
founders. We introduce the computation of w(i)a in the follow-
ing section.
F. Balancing Module
The predicted probability of receiving treatment is further
leveraged for generating weights for each individual to balance
the confounding. We compute the weights using inverse prob-
ability of treatment weighting (IPTW) and extend to dynamic
setting as follows,
w
(i)
t =
Pr(A)
aˆ
(i)
t
+
(1− Pr(A))
(1− aˆ(i)t )
(12)
where Pr(A) denotes the probability of being in treated group
and aˆ(i)t is the predicted probability of receiving treatment
given the current observed data and historical information. We
take average of weights computed at each time stamp denoted
as w(i)a .
G. Loss Function
The total loss function for the proposed method is defined
as,
L = Ly + γLa + λ‖W‖2 (13)
where Ly is the factual prediction loss between estimated
and observed factual outcomes, La is the loss from treatment
prediction, γ, λ are parameters to balance the loss function.
The last term is L2 regularization on model parameters W .
The training process of DSW is presented in Algorithm 1.
Algorithm 1 DSW Model
Input: data of i-th patient: time-varying covariates x(i)t , static
covariates c, treatment assignments a(i)t ;
Output: potential outcome yiT+τ ;
1: Randomly initialize embedding matrix Wemb for time-
varying covariates, GRU parameters Wf , Wr, Wh, Vf ,
Vr, bf , br, attention parameters Wα;
2: repeat
3: for covariate v in x(i)t do
4: Obtain the embedding of v using Eq. (2);
5: Obtain q(i)t using Eq. (3);
6: Input the q(i)t and a
(i)
t into GRU and obtain h
(i)
t
using Eq. (4);
7: Compute the attention weights using Eq. (5); (6)
8: Obtain z(i)t using Eq. (7)
9: end for
10: Predict the treatment aˆ(i)t using Eq. (8);
11: Compute the weights for each patient using Eq. (12)
12: Calculate the treatment prediction loss using Eq. (9);
13: Predict the potential outcome yˆ(i)T+τ using Eq. (10);
14: Calculate the outcome prediction loss using Eq. (11);
15: Update parameters according to gradient of mean loss;
16: until convergence
III. EXPERIMENTAL SETUP
To evaluate the performance of the proposed model, we
conduct comprehensive comparison experiments on three dif-
ferent datasets: fully-synthetic dataset, semi-synthetic dataset
and real-world dataset.
A. Datasets and Simulation
1) Synthetic Dataset: As introduced in the previous section,
the treatment assignments a(i)t at each time stamp are influ-
enced by the confounders q(i)t , which are consist of previous
hidden confounders z(i)t−1, current time-varying covariates x
(i)
t
and static features c(i). We first simulate x(i)t and z
(i)
t for each
patient at time t following p-order autoregressive process [18]
as,
x
(i)
t,j =
1
p
p∑
r=1
(αr,jx
(i)
t−r,j + βra
(i)
t−r) + ηt
z
(i)
t,j =
1
p
p∑
r=1
(µr,jz
(i)
t−r,j + υra
(i)
t−r) + t
(14)
where x(i)t,j and z
(i)
t,j denote the j-th column of x
(i)
t and z
(i)
t ,
respectively. For each j, αr,j , µr,j ∼ N (1 − (r/p), (1/p)2)
control the amount of historical information of last p time
stamps incorporated to the current representations. βr, υr ∼
N (0, 0.022) controls the influence of previous treatment as-
signments. ηt, t ∼ N (0, 0.012) are randomly sampled noises.
To simulate the treatment assignments, we generate 1000
treated samples and 3000 control samples. For treated samples,
we randomly pick the treatment initial point among all time
stamps. The treatments starting from the initial point are all
set to 1. For the control samples, the treatments at each time
stamp are all set to 0.
The confounders q(i)t at time stamp t and outcome y
(i)
T+τ
can be simulated using the hidden confounders and current
covariates as follows,
q
(i)
t = γh
1
t
t∑
r=1
z(i)r + (1− γh)g([x(i)t , c(i)])
y
(i)
T+τ = w
>q(i)T + b
(15)
where γh is the parameter to control the influence of
hidden confounders, w ∼ U(−1, 1) and b ∼ N (0, 0.1). The
function g(·) maps the concatenated feature vectors [x(i)t , c(i)]
into the hidden space. In this paper, for each individual,
we simulate 100 time-varying covariates, 5 static covariates
with 10 time stamps in total. We modify the value of γh ∈
{0.1, 0.3, 0.5, 0.7} and obtain four variants of the current
dataset.
2) Semi-synthetic Dataset based on MIMIC-III: With a
similar simulation process, we construct a semi-synthetic
dataset based on a real-world dataset: Medical Information
Mart for Intensive Care version III (MIMIC-III) [14]. MIMIC-
III has more than 61,000 ICU admissions from 2001 to 2012
with recorded patients demographics and temporal informa-
tion, including vital signs, lab tests, and treatment decisions.
We extracted 11,715 adult sepsis patients fulfilling the sepsis-
3 criteria [19] as our studied cohort from MIMIC-III since
sepsis contributes to up to half of all hospital deaths and is
associated with more than $24 billion in annual costs in the
United States [20].
Here, we obtain 27 time-varying covariates (vital signs:
temperature, pulse rate, glucose, etc; lab tests: potassium,
sodium, chloride, etc) and 12 static demographics (i.e., age,
gender, race, height, weight, etc.) as potential confounding
variables. The full list of covariates is available at Github1.
We consider vasopressors as treatments since they are com-
monly used in septic patients. As the MIMIC-III dataset is
real world observational data, then it is impossible to obtain
the counterfactual outcomes for calculating the ground truth
treatment effect. Therefore, we simulate the potential outcomes
for each patient using the observed covariates and treatment
assignments. The simulation process is similar to the way we
generate fully-synthetic dataset, with the exception that we
only need to synthesize the potential outcomes (using Eq. 15).
By varying the values of γh ∈ {0.1, 0.3, 0.5, 0.7}, we have
four variants of the current datasets.
3) Real world Dataset: MIMIC-III: To evaluate the perfor-
mance of our model in a real-world application, we design a
causal inference setting based on the MIMIC-III dataset. (1)
Treatment. We consider two available treatment assignments:
vasopressors (vaso) and mechanical ventilator (mv). For each
treatment option, we separately evaluate its causal effect on
the important outcome signals. (2) Outcomes. To evaluate
the treatment effect of vasopressors, we use mean blood
pressure (Meanbp) as target outcomes since vasopressors are
highly related to Meanbp. For mechanical ventilator, we
adopt oxygen saturation (SpO2) as outcome since ventilator
is usually assigned to patients with the difficulty of breathing.
(3) Confounders. We consider the same confounders as in
synthetic dataset (27 time-varying covariates and 12 static
demographics).
B. Methods for comparison
To evaluate the performance of the proposed framework in
estimating the ITE, we conduct comparison experiments on
the following state-of-the-art causal inference methods,
• Linear Regression (LR). LR directly regard the treatment
as an additional feature for potential outcome prediction. It
ignores the confounders and selection bias in observational
data.
• Random Forest (RF). The training process is same as LR
(using treatment as a feature). We vary the number of trees
in range {50, 60, .., 150} and select best parameter setting
on validation set.
• K-Nearest Neighbor Matching (KNN) [21]. KNN is a
matching based method that estimates the counterfactual
outcomes of treated (control) group from K-nearest neigh-
bors in control (treated) group. We attempts three different
distance metrics euclidean, minkowski and mahalanobis,
and choose the the metric yields best performance on the
validation dataset.
• Propensity Score Matching (PSM) [6]. PSM is also a
matching based method but instead use propensity score to
measure the distance among individuals. Commonly, logistic
regression is adopted for propensity score estimation. For
logistic regression, we try different solvers: liblinear, lbfgs,
1https://github.com/ruoqi-liu/DSW
sag and saga on the training set and select the solver with
best performance on the validation set.
• Counterfactual Regression (CFR) [9], [10]. CFR is deep
representation learning based method. CFR has four differ-
ent variants according the selection of distribution balanc-
ing metrics: Maximum Mean Discrepancy (CFR MMD),
Wasserstein (CFR WASS), BNN, TARNet.
• Causal Forest (CF) [8]. CF is an extension of RF for
estimating the ITE, which is designed for causal effect
estimation.
• Bayesian Additive Regression Trees (BART) [7]. BART
is a non-parametric Bayesian regression tree model, which
takes the covariates and treatment as inputs and outputs the
distribution of outcomes.
C. Performance Measurement
To evaluate the estimated ITE, we adopt mean squared error
(MSE) between the ground truth and estimated ITE as follows,
PEHE =
1
N
N∑
i=1
((y
(i)
1 − y(i)0 )− (yˆ(i)1 − yˆ(i)1 ))2, (16)
which is also known as Precision in Estimation of Heteroge-
neous Effect (PEHE). Typically, we report the rooted PEHE√
PEHE in our paper. We are also interested in the causal
effect over the whole population to help determine whether a
treatment should be assigned to population. Then we calculate
the mean absolute error (MAE) between the ground truth and
estimated and average treatment effect (ATE):
ATE = | 1
N
N∑
i=1
(y
(i)
1 − y(i)0 )−
1
N
N∑
i=1
(yˆ
(i)
1 − yˆ(i)0 )| (17)
Additionally, we adopt rooted mean squared error (RMSE)
between the estimated factual outcomes and ground truth
outcomes to evaluate the performance on factual prediction
task as follows,
RMSE =
√√√√ 1
N
N∑
i=1
(yˆ
(i)
t − y(i)t ) (18)
D. Implement Details
The model is implemented and trained with Python 3.6 and
PyTorch 1.4 2, on a high-performance computing cluster with
four NVIDIA TITAN RTX 6000 GPUs. We train our model
using the adaptive moment estimation (Adam) algorithm with
a batch size of 128 subjects and the learning rate is 0.001.
The data is randomly split into training, validation and test
sets with a ratio of 70%, 10%, 20%. The information from
a given patient is only present in one set. The validation
set is used to improve the models and select the best model
hyper-parameters. We report the performance of our model
and baselines on the test set. We use
√
PEHE and ATE error
to measure the models’ performance on ITE estimation, and
RMSE for factual prediction. As all baseline methods are orig-
inally designed for static environment, we run these models
2https://pytorch.org/
independently on each time stamp and average the evaluation
metrics over all time stamps. The code and more implementa-
tion details are available at https://github.com/ruoqi-liu/DSW.
IV. RESULTS
We now report the performance of DSW on synthetic, semi-
synthetic and real-world datasets. We focus on answering the
following research questions by our experimental results:
• Q1: How precise is DSW on ITE estimation?
• Q2: How accurate is DSW on factual prediction task (i.e.,
outcome prediction)?
• Q3: How can DSW be used for personalized medicine?
A. How precise is DSW on ITE estimation?
We conduct comprehensive comparison experiments on
synthetic and semi-synthetic datasets and report
√
PEHE and
ATE on each dataset. By varying the parameter γh that controls
the influence of hidden confounders, we evaluate the how
precise is DSW on ITE estimation under different value of γh.
Results on Synthetic Dataset Table II shows the perfor-
mance of our method and baselines on fully-synthetic dataset
evaluated by
√
PEHE and ATE. The values shown in the
table are averaged on 10 realizations. We observe that DSW
outperforms all other baselines with different value of γh,
which confirms that our designed framework can better capture
the characteristics of longitudinal data and generate accurate
estimation of ITE.
Generally speaking, the representation learning based ap-
proaches achieve better performance compared with base
methods, matching based methods and tree based methods.
Since those linear approaches are not designed for causal
effect estimation, they may not able to control the influence of
confounding variables. The matching based methods consider
the similarity information among treated and control groups
to alleviate the selection biases. However, their estimation
becomes inaccurate when dealing with high-dimensional and
complex data. Tree and forest based method achieve compara-
ble performance with basic random forest method since these
two methods are established upon the random forest.
The representation learning based methods use the deep
neural network to model the representations of confounding
variables. Their methods achieve the best performance among
all baselines. CFR MMD, CFR WASS, BNN and TARNet
share the similar design of neural network, with exception
that they adopt different strategies to minimize the distance
between treated and control groups. Specifically, CFR MMD
and CFR WASS have the same outcome prediction networks,
but the former uses Maximum Mean Discrepancy (MMD) and
the latter uses Wasserstein (WASS) to balance the distributions.
BNN regards the treatment as additional feature and minimize
the distances between treated and control group in latent
space. TARNet is a vanilla version without balancing property.
Among all these four representation learning based meth-
ods, we observe that CFR MMD and CFR WASS generally
achieve better performance than other two methods. Although
representation learning based models outperform the other
baselines, they ignore the time-varying confounders and lose
lots of temporal information, which are crucial and common
in healthcare data. Our proposed DSW successfully captures
the temporal information and thus outperform the baselines.
Note that, four variants of simulated datasets (γh ∈
{0.1, 0.3, 0.5, 0.7}) are not comparable, since the distribution
of simulated outcomes are not same. With the increasing of
γh, less portion of observed confounders are included, which
results in smaller values of outcomes. Instead, we focus on
the performance of methods within each dataset.
Results on Semi-synthetic Dataset We demonstrate the per-
formance of the proposed model and baselines on a semi-
synthetic dataset based on MIMIC-III. As shown in Table
III, DSW achieves the best performance among other baseline
methods in terms of
√
PEHE and ATE. We vary the value of
γh to control the influence of hidden confounders and conduct
comparison experiments under each value of γh.
We observe that representation learning based methods
in general outperform most causal inference methods which
demonstrate that deep learning architecture with distribution
balancing is beneficial to the ITE estimation. Base models
(LR and Random Forest) cannot perform very well since
they ignore the selection bias and confounding factors. As for
matching based methods, they consider the similarity infor-
mation among individuals to alleviate selection bias. Among
all the baselines, DSW considers the temporal information in
the time-varying data, and thus generate unbiased and accurate
treatment effect estimation.
B. How accurate is DSW on factual prediction?
In real-world data, we have no access to counterfactual
outcomes for calculating the true treatment effect, and thus we
cannot compute the
√
PEHE and ATE. Instead, we evaluate
the performance of our model through a factual prediction
task. We measure the RMSE between observed (factual)
outcomes and estimated outcomes on two treatment-outcome
pairs: vasopressor-meanBP and ventilator-SpO2.
Table IV shows the estimated RMSE of two selected pairs.
Since causal effect methods are not initially designed for
factual prediction, we adopt four baselines from each category
that can be adapted for factual prediction task: LR, KNN, CFR
(WASS) and BART. Matching based methods aim to estimate
the counterfactual and cannot be directly used for factual
inference. We adapt the KNN matching for factual prediction
by combining the treatments as additional features to predict
factual outcomes. Among four representation learning based
methods, they achieve relative comparative performance in two
datasets, so we use CFR WASS as a representative for this kind
of method. In two forest based methods, CF directly outputs
the estimated ITE without any inference of factual outcomes,
so we use BART as our baseline.
As shown in TABLE IV, DSW outperforms all the baselines,
which demonstrates that our model yields accurate estimation
on factual data. Among the baselines, we find that representa-
tion learning based method (CFR WASS) performs better than
TABLE II
Performance comparison on synthetic datasets. We construct four variants of datasets by varying the value of γh ∈ {0.1, 0.3, 0.5, 0.7}. Here, we report the
estimated
√
PEHE and ATE of each method among four datasets.
γh = 0.1 γh = 0.3 γh = 0.5 γh = 0.7
Method
√
PEHE ATE
√
PEHE ATE
√
PEHE ATE
√
PEHE ATE
Base model
LR 0.640 0.551 0.648 0.558 0.656 0.566 0.663 0.574
Random Forest 0.656 0.552 0.658 0.553 0.660 0.555 0.663 0.557
Matching based
KNN [21] 0.713 0.604 0.718 0.608 0.724 0.611 0.729 0.615
PSM [6] 0.699 0.591 0.708 0.602 0.714 0.607 0.720 0.611
CFR MMD [10] 0.587 0.485 0.594 0.491 0.597 0.492 0.600 0.495
Representation CFR WASS [10] 0.571 0.470 0.574 0.473 0.576 0.474 0.580 0.476
learning based BNN [9] 0.586 0.488 0.593 0.495 0.595 0.496 0.597 0.498
TARNet [10] 0.606 0.512 0.610 0.516 0.615 0.520 0.619 0.523
Forest based
Causal Forest [8] 0.604 0.511 0.612 0.517 0.615 0.521 0.618 0.523
BART [7] 0.608 0.520 0.614 0.525 0.621 0.530 0.619 0.528
Ours DSW 0.491 0.391 0.469 0.372 0.485 0.384 0.515 0.397
TABLE III
Performance comparison on semi-synthetic MIMIC-III datasets. We construct four variants of datasets by varying the value of γh ∈ {0.1, 0.3, 0.5, 0.7}.
Here, we report the estimated
√
PEHE and ATE of each method among four datasets.
γh = 0.1 γh = 0.3 γh = 0.5 γh = 0.7
Method
√
PEHE ATE
√
PEHE ATE
√
PEHE ATE
√
PEHE ATE
Base model
LR 0.823 0.660 1.414 1.134 1.474 1.233 1.542 1.336
Random Forest 0.837 0.671 1.422 1.143 1.484 1.245 1.553 1.349
Matching based
KNN [21] 0.818 0.650 1.408 1.137 1.472 1.237 1.543 1.337
PSM [6] 0.767 0.607 1.417 1.143 1.477 1.240 1.548 1.340
Representation
learning based
CFR MMD [10] 0.803 0.643 1.257 0.972 1.356 1.099 1.527 1.318
CFR WASS [10] 0.800 0.641 1.256 0.972 1.370 1.118 1.556 1.352
BNN [9] 0.802 0.643 1.287 1.006 1.337 1.080 1.515 1.305
TARNet [10] 0.829 0.664 1.256 0.972 1.373 1.120 1.527 1.318
Forest based
Causal Forest [8] 0.796 0.639 1.413 1.134 1.473 1.233 1.540 1.335
BART [7] 0.785 0.631 1.413 1.135 1.472 1.234 1.538 1.336
Ours DSW 0.522 0.432 0.604 0.523 0.672 0.601 0.722 0.652
TABLE IV
Factual Prediction on the MIMIC-III dataset. We select two
treatment-outcome pairs: Vasopressor-Meanbp and Ventilator-SpO2, and
report RMSE between estimated factual outcome and ground truth.
MIMIC Dataset (RMSE)
Method Vent-SpO2 Vaso-Meanbp
LR 0.909 0.973
KNN [21] 0.901 1.030
CFR WASS [10] 0.870 1.011
BART [7] 0.873 0.966
DSW 0.814 0.814
the linear regression method (LR) and matching based method
(KNN), which is consistent with TABLE II and III.
C. How can DSW be used for personalized medicine?
Based on observational data, we are going to show that
our model can adjust time-varying confounders, and generate
unbiased and accurate estimation of treatment effect. In this
case, our model could potentially help physicians determine
whether to apply a specific treatment to a patient. We examine
the usages of Vasopressor and Ventilator in the analysis, which
are commonly used treatments for septic patients.
Vasopressor-Meanbp pair Vasopressor (a.k.a., antihypoten-
sive agent) is a group of medications that tend to raise low
blood pressure. The patients are expected to have normal blood
pressure after receiving a vasopressor. To demonstrate that
our model can adjust time-varying confounders, we plot the
distribution of ground truth (observed) and predicted Meanbp
values after the patients have received vasopressor in Fig. 3.
According to the threshold of the normal range of Meanbp (70-
100 mmHg), we separate the patients into two groups: one is
the patients with observed MeanBP values below 70 mmHg,
the other is the patients with observed Meanbp values above
70 mmHg. Figure. 3(a) shows the distribution of patients with
Meanbp below 70 mmHg. We observe this group of patients
remains low blood pressure even after receiving vasopressor
and the average value is far lower than 70 mmHg. If mainly
based on the observed data, we may conclude that vasopressor
has no effect on raising blood pressure and are unnecessary
to be assigned to patients with low blood pressure. However,
the predicted values given by our model are higher than
the observed values and the average Meanbp belongs to the
normal range, which indicates that vasopressor should have
a beneficial effect on the blood pressure. Figure 3(b) shows
the distribution of patients with Meanbp above 70 mmHg. For
these patients whose Meanbp remains in the normal range
after receiving vasopressor, the predicted values are still within
the normal range, which indicates that vasopressor should be
(a) (b)
(c) (d)
Fig. 3. Distribution of ground truth MeanBP and predicted MeanBP given vasopressor as treatment. Fig. 3(a) displays the distribution of patients with observed
MeanBP below than 70 mmHg. Fig. 3(b) displays the distribution of patients with observed MeanBP above 70 mmHg. Fig. 3(c) displays the distribution of
patients with observed SpO2 below than 95%. Fig. 3(d) displays the distribution of patients with observed SpO2 above 95%.
assigned to this group of patients to maintain normal blood
pressure. If not, their situation may become worse.
Ventilator-SpO2 pair A ventilator is a machine that delivers
breaths to a patient who is physically unable to breathe,
or breathing insufficiently to maintain blood oxygen. We
monitor the value of oxygen saturation (SpO2) to estimate
the treatment effect.
Similarly, we show the distribution of ground truth and pre-
dicted SpO2 values of patients who have received a ventilator
during the observational window in Fig. 3. As the normal range
of SpO2 is 95-100%, we separately plot the distribution of
patients with observed SpO2 values below 95% in Fig. 3(c),
and the distribution of patients with observed SpO2 values
above 95% in Fig. 3(b). We observe that, for patients with
observed SpO2 lower than normal value, the distribution of
predicted SpO2 values lies in normal range with an average
of 96.57%. And for patients with observed SpO2 in the normal
range, our predicted values still belong to the normal range.
Results show that our model adjusts time-varying con-
founders and is able to generate unbiased and accurate ITE
on important outcome signals (vasopressor’s effect on blood
pressure and ventilator’s effect on blood oxygen in our anal-
ysis). Thus, it could potentially assist physicians to determine
whether to introduce a treatment to a specific patient, paving
the way for personalized medicine.
V. RELATED WORK
In this section, we review the related work for ITE estima-
tion using static and time-varying observational data. We first
introduce the causal effect learning framework on static data,
and then the framework based on time-varying data.
Learning causal effects with static data According to the
way to control the confounders, existing work with static ob-
servational data can be divided into four groups: 1) Matching-
based methods; 2) Tree-based methods; 3) Reweighting-based
methods; 4) Representation-based methods. The matching-
based methods are adopted to estimate the counterfactual
from the nearest neighbors. The distances among individuals
can be measured in several ways (i.e., Euclidean distance,
propensity scores). For example, propensity score matching
(PSM) [6] is to match a treated (control) sample to a set
of control (treated) samples with similar propensity scores.
Tree-based methods are also widely adopted in causal effect
estimation. Bayesian additive regression trees (BART) [7] is a
non-parametric Bayesian regression tree model based on the
strong ignorability assumption. It is easy to implement and
free from parameter adjustment. Causal Forest (CF) [8] is also
a tree-based causal effect estimation method, which estimates
the treatment effect at the leaf node by mapping the original
covariate into tree and forests. The reweighting-based methods
attempt to re-weight samples in the population for correcting
the bias in observational data. For example, inverse probability
of treatment weighting (IPTW) [6] removes the confounding
by assigning a weight to each individual in the population. The
weights are calculated based on the propensity score. Recently,
representation learning methods are proposed for causal effect
estimation via balancing the distribution between treated and
control groups in hidden space [9], [10]. Moreover, Yao et al.
[11] incorporate the local similarity among individuals with
population-level distribution balancing in latent space to better
estimate ITE. Yoon et al. propose to use generative adversarial
nets (GAN) for inferring the counterfactual outcomes based on
factual outcomes. Shi et al. [22] jointly model the propensity
prediction and potential outcome prediction as a multi-task
learning problem.
Though existing work shows great performance in causal
effect estimation, they still have some limitations. First, most
of them are built upon strong ignorability assumption without
considering the influence of hidden confounders. This con-
strain has been shown to lead to bias in estimating causal
effects [13]. Moreover, existing work is initially designed for
static data, which is not easy to adapt for ITE estimation under
dynamic longitudinal setting.
Learning causal effects with time-varying data As estimat-
ing causal effect from observational data is significant and
most observational data contains sequential information, some
work has been proposed for dealing time-varying confounders.
In statistics and epidemiology domains, a group of methods
use the inverse probability of treatment and g-formula based
method to estimate causal effect with sequential data [23],
[24]. More recently, Lim et al. [25] propose a recurrent
marginal structural network for predicting the patient’s po-
tential response to a series of treatments. Bica et al. [26]
adopt adversarial training techniques to balance the historical
confounding variables. Their method is based on the strong
ignorability assumption. Later, Bica et al. [27] relax the
assumption on strong ignorability and propose to estimate the
treatment response with the existence of hidden confounders.
VI. CONCLUSION
In this paper, we propose Deep Sequential Weighting
(DSW), a deep learning based framework for estimating ITE
with time-varying confounders. Specifically, DSW infers the
hidden confounders by incorporating the current treatment
assignments and historical information using a deep recurrent
weighting neural network. When combined with current ob-
served data, the learned representations of hidden confounders
are leveraged for potential outcome prediction and treatment
prediction. We compute the time-varying inverse probabilities
of treatment for re-weighting the population. Comprehensive
experiments on fully-synthetic, semi-synthetic, and real-world
datasets demonstrate the effectiveness of DSW when compared
to state-of-the-art baseline methods. Results illustrate that our
model can generate unbiased and accurate treatment effect by
conditioning on time-varying confounders. Our model has the
potential to be used as part of clinical decision support systems
to determine whether a treatment is needed for a specific
patient, paving the way for personalized medicine.
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